Morning All!

Tristel (TSTL)

295p - £127.5m

Final Results For The 12 Months To End June 2017 – Revenue up 19% to £20.3m, £17.1m last time. PBT (before share-based payments) up 24% to £4.1m, £3.3m last time. EPS 8.06p, up 61% since last time, 5.01p. Standard Dividend increased by 21% to 4.03p, 3.33p last time. Net cash of £5.1m, down from £5.7m last time. These results seem slightly ahead of forecasts but on a PER of 36.6 were probably expected.

StatPro (SOG)

151p - £97.7m

Q3 Trading Update For The 9 Months To End September 2017 – In-line expectations with this impressive statement – “In the 12 months to 30 September 2017, Group Annualised Recurring Revenue ("ARR"), increased by 40% to £52.9 million (September 2016: £37.9 million at constant currency), which includes the addition of ARR for Delta, the cloud-based risk and performance analytics service, acquired in May 2017”. And, the Chief Exec had this to add “"We continue to make solid progress migrating our software to pure cloud-based delivery which will improve our operational efficiency and increase our margins. The integration of Delta is also going well.  Our roadmap to add the excellent and complementary Delta functionality into our flagship cloud platform, Revolution, has been well received by clients". On a PER of 22.6, perhaps worth a position here ahead of seeing the actual profits on this Revenue increase.

Oxford Metrics (OMG)

 58.75p - £72.3m

Trading Update For The 12 Months To End September 2017 – Expecting to report Revenue and PBT ahead of market expectations. And the board is pleased to report “the Group has made good progress during this first year of the Group's five-year growth plan and is on track to achieve the goals we stated in December 2016 to double profits and triple recurring revenue by 2021”. An impressive update and well liked by Stockopedia with a StockRank of 93. Really liking this!

Zytronic (ZYT)

602.5p - £96.7m

Trading Update For The 12 Months To End September 2017 – Results expected to be in-line with market expectations. Up 50% in the past 12 months I just don’t see how the forecasts justify the PER of 20 here – Other than the overly impressive…

Finish reading with a 14 day trial

or Unlock with your email

Already have an account?
Login here